Peregrine Pharmaceuticals shares owned by Morgan Stanley
Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Peregrine Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Peregrine Pharmaceuticals held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Peregrine Pharmaceuticals by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $4.2M | 594k | 7.14 |
| 2024-03-31 | $9.3M | 1.4M | 6.70 |
| 2023-12-31 | $6.9M | 1.1M | 6.50 |
| 2023-09-30 | $9.8M | 1.0M | 9.50 |
| 2023-06-30 | $15M | 1.1M | 13.97 |
| 2022-12-31 | $16M | 1.2M | 13.78 |
| 2022-06-30 | $16M | 1.2M | 13.70 |
| 2022-03-31 | $25M | 1.2M | 20.37 |
| 2021-06-30 | $15M | 599k | 25.65 |
| 2020-12-31 | $4.8M | 414k | 11.55 |
| 2020-09-30 | $66k | 8.6k | 7.58 |
| 2020-06-30 | $236k | 36k | 6.55 |
| 2020-03-31 | $57k | 11k | 5.12 |
| 2019-12-31 | $799k | 104k | 7.67 |
| 2019-09-30 | $119k | 22k | 5.31 |
| 2019-03-31 | $56k | 13k | 4.24 |
| 2018-12-31 | $339k | 83k | 4.10 |
| 2018-09-30 | $591k | 86k | 6.87 |
| 2018-06-30 | $473k | 121k | 3.92 |
| 2018-03-31 | $34k | 12k | 2.89 |